Lin Biting, Ling Yunzhi, Zhou Gengyu, Ruan Ziqing, Chen Fan, Chen Simiao, Weng Tingting, Zhu Yuanfan, Lin Jingyi, Yu Ling, Lin Kaiyang
Fujian University of Traditional Chinese Medicine Fuzhou Fujian China.
Department of Cardiology Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital Fuzhou Fujian China.
Chronic Dis Transl Med. 2025 Jul 21;11(3):213-223. doi: 10.1002/cdt3.70013. eCollection 2025 Sep.
The ratio of high-density lipoprotein cholesterol (HDL-C) to low-density lipoprotein cholesterol (LDL-C) predicts cardiovascular disease (CVD) endpoints, yet its prognostic validity in high-risk populations and for type 2 diabetes mellitus (T2DM)-related adverse events remains unestablished.
This study included 32,609 people aged 35-75 years in Fujian Province, China, who were at high risk for CVD. The primary endpoint was all-cause mortality during follow-up. Cox proportional hazard models and restricted cubic spline (RCS) analysis were used to evaluate the correlation between the HDL-C/LDL-C ratio and the endpoints.
On the basis of the restricted RCS curve, the participants were classified as having a low (< 0.3), middle (0.3-0.5), or high (> 0.5) HDL-C/LDL-C ratio. Multivariate Cox regression analyses revealed that the risk of all-cause mortality (HR = 1.48, 95% CI 1.14-1.93, < 0.01 for low; HR = 1.30, 95% CI 1.06-1.58, < 0.05 for high) was increased in the low and high groups. Participants without T2DM who were at high risk for CVD had similar prognoses (HR = 1.65, 95% CI 1.19-2.28, < 0.01 for low; HR = 1.35, 95% CI 1.05-1.74, < 0.01 for high). However, this association was not found in participants with T2DM who were at high risk for CVD.
HDL-C/LDL-C can be used to predict the prognosis of individuals at high risk for CVD, and maintaining HDL-C/LDL-C ratios between 0.3 and 0.5 may be the most helpful range for this population. Furthermore, maintaining this ratio range holds clinical significance for cohorts without T2DM, although further exploration is needed in this T2DM cohort.
高密度脂蛋白胆固醇(HDL-C)与低密度脂蛋白胆固醇(LDL-C)的比值可预测心血管疾病(CVD)终点事件,但其在高危人群以及2型糖尿病(T2DM)相关不良事件中的预后有效性尚未明确。
本研究纳入了中国福建省32609名年龄在35至75岁之间的CVD高危人群。主要终点为随访期间的全因死亡率。采用Cox比例风险模型和限制性立方样条(RCS)分析来评估HDL-C/LDL-C比值与终点事件之间的相关性。
根据限制性RCS曲线,将参与者分为HDL-C/LDL-C比值低(<0.3)、中(0.3 - 0.5)或高(>0.5)三组。多变量Cox回归分析显示,低比值组和高比值组的全因死亡风险均升高(低比值组:HR = 1.48,95%CI 1.14 - 1.93,P<0.01;高比值组:HR = 1.30,95%CI 1.06 - 1.58,P<0.05)。无T2DM的CVD高危参与者有相似的预后情况(低比值组:HR = 1.65,95%CI 1.19 - 2.28,P<0.01;高比值组:HR = 1.35,95%CI 1.05 - 1.74,P<0.01)。然而,在有T2DM的CVD高危参与者中未发现这种关联。
HDL-C/LDL-C可用于预测CVD高危个体的预后,对于该人群而言,将HDL-C/LDL-C比值维持在0.3至0.5之间可能是最有益的范围。此外,维持这一比值范围对无T2DM的队列具有临床意义,不过在T2DM队列中还需要进一步探索。